Relevant bibliographies by topics / European Patent Office / Journal articles
To see the other types of publications on this topic, follow the link: European Patent Office.

Journal articles on the topic 'European Patent Office'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'European Patent Office.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Melvin, Thomas C. "European Patent Office." Journal of Business & Finance Librarianship 8, no. 1 (2002): 55–62. http://dx.doi.org/10.1300/j109v08n01_06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Giroud, Gérard. "The European Patent Office and its patent information policy." Electronic Library 9, no. 6 (1991): 329–32. http://dx.doi.org/10.1108/eb045095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Verbandt, Yves, and Els Vadot. "Non-patent literature search at the European Patent Office." World Patent Information 54 (September 2018): S72—S77. http://dx.doi.org/10.1016/j.wpi.2017.07.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stancliffe, Terence C. "{BLR 1849} Biotechnology Patent Directive - EC - European Patent Office." Biotechnology Law Report 13, no. 5 (1994): 628–29. http://dx.doi.org/10.1089/blr.1994.13.628.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Von Belvard, Peter Revy. "The European Patent Office on the way to the patent office of Europe." Technology, Law and Insurance 2, no. 4 (1997): 165–67. http://dx.doi.org/10.1080/135993797349722.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Feinäugle, Roland. "Distance learning from the European Patent Office." World Patent Information 28, no. 1 (2006): 63–74. http://dx.doi.org/10.1016/j.wpi.2005.07.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schryvers, H. J. "Online searching at the European patent office." World Patent Information 7, no. 1-2 (1985): 139–44. http://dx.doi.org/10.1016/0172-2190(85)90044-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Newton, David. "European Patent Office PATLIB 2010, Dresden, Germany." World Patent Information 33, no. 1 (2011): 86–88. http://dx.doi.org/10.1016/j.wpi.2010.09.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Demey, Yan Tang, and Domenico Golzio. "Search strategies at the European Patent Office." World Patent Information 63 (December 2020): 101989. http://dx.doi.org/10.1016/j.wpi.2020.101989.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Powell, Stephen. "European Patent Office – the first 10 years." Physics Bulletin 38, no. 9 (1987): 325. http://dx.doi.org/10.1088/0031-9112/38/9/010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Crab, E. "BEST project in the European Patent Office." World Patent Information 16, no. 3 (1994): 159–60. http://dx.doi.org/10.1016/0172-2190(94)90130-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Abbott, Alison. "European Patent Office rejects bid to revoke first plant patent." Nature 357, no. 6379 (1992): 525. http://dx.doi.org/10.1038/357525a0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Harhoff, Dietmar, and Stefan Wagner. "The Duration of Patent Examination at the European Patent Office." Management Science 55, no. 12 (2009): 1969–84. http://dx.doi.org/10.1287/mnsc.1090.1069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Anaya-Ruiz, Maricruz, Cindy Bandala, Gerardo Landeta, et al. "Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents." Recent Patents on Anti-Cancer Drug Discovery 14, no. 1 (2019): 85–94. http://dx.doi.org/10.2174/1574892813666181031154146.

Full text
Abstract:
Background: Cancer is one of the leading causes of death in the world and it is necessary to develop new strategies for its treatment because most therapies have limited access to many types of tumors, as well as low therapeutic efficacy and high toxicity.Objective:The present research aims to identify recent patents of drug delivery nanostructured systems that may have application in improving cancer treatment.Methods:Recent patents regarding the drug delivery nanostructured systems for cancer treatment were obtained from the patent databases of the six main patent offices of the world: United States Patent and Trademark Office, European Patent Office, World Intellectual Property Organization, Japan Patent Office, State Intellectual Property Office of China and Korean Intellectual Property Office.Results:A total of 1710 patent documents from 1998 to 2017 including "drug delivery nanostructured systems for cancer treatment" were retrieved. The top five countries in patent share were USA, China, South Korea, Canada and Germany. The universities and enterprises of USA had the highest amount of patents followed by institutions from China.Conclusion:There is a strong tendency for the development of new nanostructured systems for the release of drugs; particularly, in recent years, the development of nanoparticles has focused on nanodiscs, gold nanoparticles and immunoliposomes.
APA, Harvard, Vancouver, ISO, and other styles
15

Stierle, Martin. "Artificial Intelligence Designated as Inventor – An Analysis of the Recent EPO Case Law." GRUR International 69, no. 9 (2020): 918–24. http://dx.doi.org/10.1093/grurint/ikaa105.

Full text
Abstract:
Abstract This paper will focus on the issue of designating artificial intelligence systems as inventors in the current framework of European patent law. Most recently, the European Patent Office rejected two patent applications which indicated a machine called DABUS as the inventor of the claimed subject-matter. The paper will analyse the grounds of the decisions in detail, thereby reflecting on the current approach of the European Patent Office to such designations and on the concept of inventorship within the European patent system in general.
APA, Harvard, Vancouver, ISO, and other styles
16

Kasyanov, R. A., and I. M. Yazberdiev. "To the 50th Anniversary of the European Patent Convention (1973–2023)." Moscow Journal of International Law, no. 1 (May 15, 2024): 44–56. http://dx.doi.org/10.24833/0869-0049-2024-1-44-56.

Full text
Abstract:
INTRODUCTION. This paper reflects historical overview of long-standing emergence of mechanisms of judicial protections of patent rights conferred by European patens which begun even in 1950-s and ended with start of operations of the Unified Patent Court in 2023. The paper demonstrates that the establishment of the similar mechanism within the Eurasian Patent Organization or Eurasian Economic Union may require different approaches because of possible centralization of industrial property protection under Eurasian Patent Organization.METHODS AND MATERIALS. The research materials for this paper are scientific works of foreign and Russian scientists and officials of the European Patent Office and the Eurasian Patent Office, legal acts of international and regional levels and drafts thereof. Methodological basis of this research are general and special scientific methods.RESEARCH RESULTS. This paper suggests periodization in emergence and evolution of dispute resolution mechanisms for European patents, reveals rationales for establishment of the unified patent judiciary in Europe and outlines directions for further research of prospects of creation of the similar mechanism in the Eurasian region. Some findings made in this article may facilitate the growth of such researches.DISCUSSION AND CONCLUSIONS. European Union (EU) accumulated broad experience in establishment of the dispute resolution mechanisms for European patents. Due to uniqueness the Unified Patent Court is of great interest when researching prospect of improvements of the patent judiciary and quasi-judicial mechanisms under the Eurasian Patent Convention. However, trends of developments of the Eurasian Patent Organization and possible centralization of the regional protection of industrial property may testify that a Eurasian analogue of the Unified Patent Court would have a different institutional form.
APA, Harvard, Vancouver, ISO, and other styles
17

Abdulfasi, Mohammed. "The Transformative Patent Landscape in Saudi Arabia Since the Saudi Vision 2030 Announcement." Publications 12, no. 4 (2024): 47. https://doi.org/10.3390/publications12040047.

Full text
Abstract:
This study analyzes the patent landscape of Saudi Arabia from the announcement of Saudi Vision 2030 in late April 2016 to September 2024, utilizing the Patsnap database to evaluate patent grants across various organizations. The findings reveal a gradual increase in patent registrations, with Saudi Aramco leading in patent grants, followed by King Faisal University (KFU), King Fahd University of Petroleum and Minerals (KFUPM), King Abdullah University of Science and Technology (KAUST), and King Abdulaziz University (KAU). SABIC, a prominent industry player in Saudi Arabia, has registered most of its patents using its European Head Office address and holds extensive collaborations with international partners, generating numerous patents. The analysis identifies the top patent offices where KSA organizations seek protection, including the United States Patent and Trademark Office (USPTO), Saudi Authority for Intellectual Property (SAIP), European Patent Office (EPO), the China National Intellectual Property Administration (CNIPA), and the German Patent and Trade Mark Office. However, the limited number of registrations at the SAIP highlights a need for improvement. The primary application domains encompass borehole/well accessories, measurement devices, organic chemistry, computing, and chemical/physical processes. The landscape reveals that Saudi Aramco and KFUPM focus predominantly on upstream and downstream technologies, while KAU, KFU, and KAUST concentrate on life sciences. Key findings indicate a significant increase in patent activity since the vision announcement, suggesting a growing focus on innovation within Saudi Arabia. However, the concentration of patents among a few major players (Saudi Aramco and SABIC) and the underrepresentation of patents filed with the Saudi Authority of Intellectual Property (SAIP) highlight areas for improvement. This study emphasizes the necessity to support small and medium enterprises (SMEs) and healthcare research institutions to foster broader participation in innovation and protect novel technologies. This research contributes valuable insights into the current state of patenting activities in Saudi Arabia and outlines opportunities for enhancing the country’s innovation ecosystem.
APA, Harvard, Vancouver, ISO, and other styles
18

Caviggioli, Federico, Giuseppe Scellato, and Elisa Ughetto. "International patent disputes: Evidence from oppositions at the European Patent Office." Research Policy 42, no. 9 (2013): 1634–46. http://dx.doi.org/10.1016/j.respol.2013.06.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

England, P. "Parallel patent proceedings between the European Patent Office and UK courts." Journal of Intellectual Property Law & Practice 10, no. 7 (2015): 509–17. http://dx.doi.org/10.1093/jiplp/jpv055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Ezzell, Carol. "Biogen in European Patent Office row over interferon." Nature 325, no. 6100 (1987): 98. http://dx.doi.org/10.1038/325098a0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

van der Hoff, Hilary. "Antibody claims granted by the European Patent Office." Nature Biotechnology 32, no. 11 (2014): 1094–98. http://dx.doi.org/10.1038/nbt.3054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

ZIMMER, FRANZ-JOSEPH. "{BLR 2932} Biotechnology Directive-European Patent Office-ESTs." Biotechnology Law Report 18, no. 4 (1999): 304–12. http://dx.doi.org/10.1089/blr.1999.18.304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Edfjäll, C. "The DATIMTEX system of the European patent office." World Patent Information 8, no. 2 (1986): 92–97. http://dx.doi.org/10.1016/0172-2190(86)90006-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Beatty, John. "The European patent office ‘Raising the Bar’ initiative." World Patent Information 33, no. 4 (2011): 355–59. http://dx.doi.org/10.1016/j.wpi.2011.06.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Krier, Marc, and Francesco Zaccà. "Automatic categorisation applications at the European patent office." World Patent Information 24, no. 3 (2002): 187–96. http://dx.doi.org/10.1016/s0172-2190(02)00026-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Sandercock, Colin G. "{BLR 1897} Amgen - Behringwerke - Boehringer Mannheim - Erythropoietin - European Patent Office - Patents." Biotechnology Law Report 13, no. 6 (1994): 790–94. http://dx.doi.org/10.1089/blr.1994.13.790.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

ALDIERI, LUIGI, and CONCETTO PAOLO VINCI. "TECHNOLOGICAL SPILLOVERS THROUGH A PATENT CITATION ANALYSIS." International Journal of Innovation Management 20, no. 02 (2016): 1650028. http://dx.doi.org/10.1142/s1363919616500286.

Full text
Abstract:
The aim of this paper is to analyse the pattern of knowledge flows as evidenced by the patent citations in three economic areas: USA, Japan and Europe. In each economic area, we exploit information from two international patent offices data, the United States Patent and Trademarks Office (USPTO) data and the European Patent Office (EPO) data. In this way, we can investigate the link between the technological proximity and knowledge spillovers for 240 international firms. In particular, the contribution to the existing literature is twofold: First, we use an international sample so that we can compare the empirical results among different economic markets; second, we explore the robustness of results with respect to patent system features. In order to compute the technological proximity, we consider both the symmetrical measure and asymmetrical one. The empirical results indicate that there is a statistically significant correlation between technological proximity and knowledge spillovers measured by patent citations and that these results are robust with respect to patent office data used in the analysis.
APA, Harvard, Vancouver, ISO, and other styles
28

Kondratiuk, S. V. "The abuse of patentability conditions in the sphere of pharmacy in Ukraine and the EpO: upon the Example of polymorph sofosbuvir." Medicne pravo, no. 2(32) (October 10, 2023): 23–39. http://dx.doi.org/10.25040/medicallaw2023.02.023.

Full text
Abstract:
The author analyzed regulation of the patenting of polymorphs for medicinal products in Ukraine, the European Patent Office, and in countries with stringent application of patentability criteria in pharmaceutical field (Argentina and India). The author described the analysis of the decisions of the Ukrainian patent office and the Appeals Chamber of the Ministry of Economic Development and Trade concerning the refusal of issuing a patent for the polymorph of sofosbuvir, and the impact of this judgment on access of sofosbuvir for the Ukraine’s population. The author also conducted a brief comparative analysis of Ukraine with the approach of the European Patent Office as opposed to «stringent» patent offices and IGOs patentability guidelines regarding the patenting of polymorphs. It is proposed that polymorphs should be excluded from patentability in Ukraine in order to prevent the abuse of patentability conditions by the industry using polymorphs of known chemicals. Such changes should be introduced either by more precise wording in the patent law in order to correct the deficiencies regarding new forms of known medicines in the Article 7(7) of the Law of Ukraine «On Protection of Inventions and Utility Models» or by introducing relevant provisions by development of patentability guidelines for pharmaceuticals on a sub-legislative level.
APA, Harvard, Vancouver, ISO, and other styles
29

Oriakhogba, Desmond Osaretin. "What If DABUS Came to Africa? Visiting AI Inventorship and Ownership of Patent from the Nigerian Perspective." Business Law Review 42, Issue 2 (2021): 89–99. http://dx.doi.org/10.54648/bula2021013.

Full text
Abstract:
Dr Stephen Thaler’s artificial intelligent machine – DABUS (Device for the Autonomous Bootstrapping of Unified Sentience) recently created two patentable devises that were the subject of patent applications in the European Patent Office (EPO), the United Kingdom Intellectual Property Office (UKIPO), the United States Patent and Trademark Office (USPTO) and other patent offices, including under the Patent Cooperation Treaty system. Thaler named DABUS as the inventor in the applications and claimed to have acquired the right to patent from DABUS as its owner, employer and successor in title. The EPO, UKIPO and USPTO recently rejected the applications on the ground of non-compliance with the formal requirements of their respective patent legislation for failing to name a natural person as inventor. Based on a comparative study conducted as a desk research, the paper reviews the EPO, UKIPO and USPTO decisions against the backdrop of the ongoing policy and academic conversations on AI and patent policy. It then situates the decisions within the African context, especially under the Nigerian patent regime, and determines whether the Nigerian patent office will reach a different conclusion from those made by the EPO, UKIPO and USPTO should a similar patent application be considered in Nigeria. Artificial Intelligence, Inventorship, Patent Regimes, DABUS, EPO, UKIPO, USPTO, Nigeria
APA, Harvard, Vancouver, ISO, and other styles
30

Danguy, Jérôme, and Bruno van Pottelsberghe de la Potterie. "Cost-Benefit Analysis of the Community Patent." Journal of Benefit-Cost Analysis 2, no. 2 (2011): 1–43. http://dx.doi.org/10.2202/2152-2812.1030.

Full text
Abstract:
For more than 40 years, governments and professional associations have acted, voted or lobbied against the implementation of the Community Patent (COMPAT, officially called the EU Patent). The econometric results and simulations presented in this paper suggest that, thanks to its attractiveness in terms of market size and a sound renewal fee structure, the COMPAT would drastically reduce the relative patenting costs for applicants while generating more income for the European Patent Office and most National Patent Offices. The loss of economic rents (€400 million would be lost by patent attorneys, translators and lawyers) and the drop of controlling power by national patent offices elucidate further the observed resistance to the Community Patent.
APA, Harvard, Vancouver, ISO, and other styles
31

Hingley, Peter, and Marc Nicolas. "Methods for forecasting numbers of patent applications at the European Patent Office." World Patent Information 26, no. 3 (2004): 191–204. http://dx.doi.org/10.1016/j.wpi.2003.12.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Rutkowska-Sowa, Magdalena. "Functioning of UPRP, EUIPO, EPO and WIPO During Covid-19 Pandemic – an Overview." Teka Komisji Prawniczej PAN Oddział w Lublinie 13, no. 2 (2020): 451–60. http://dx.doi.org/10.32084/tekapr.2020.13.2-34.

Full text
Abstract:
The purpose of this review is to present an overview of the various preventive measures introduced by the bodies dealing with intellectual property protection with the aim of maintaining the continuity of proceedings regarding industrial property during COVID-19 pandemic. Author presents actions taken by the Patent Office of the Republic of Poland (UPRP), the European Union Intellectual Property Office (EUIPO), European Patent Office (EPO) and World Intellectual Property Organization (WIPO). Legal status as of 29 April 2020.
APA, Harvard, Vancouver, ISO, and other styles
33

Marschall, Stefan. "Concept for a Multinational Patent Search using Elements of Blockchain Technology." GRUR International 69, no. 3 (2020): 225–32. http://dx.doi.org/10.1093/grurint/ikaa014.

Full text
Abstract:
Abstract Blockchain Elements Integrated Multinational Search (BEIMS) is a response to an ongoing discussion about the search and examination procedures employed in patent offices, relaunched in 2018 when German law firms sent an open letter to the President of the European Patent Office. The BEIMS concept turns away from patent examiners working by themselves in isolation, and instead involves experts from different offices working in close co-operation. BEIMS integrates elements of Blockchain Technology – such as decentralized network, competition and consensus building – with the participation of several national and/or regional patent offices, and involves financial incentives. The co-operating patent offices are coequal and, as a consequence, a multinational search report is generated with cited prior art determined and evaluated by patent examiners of different patent offices in due time.
APA, Harvard, Vancouver, ISO, and other styles
34

Gates, C. "Patenting the Life Sciences at the European Patent Office." Cold Spring Harbor Perspectives in Medicine 4, no. 12 (2014): a020792. http://dx.doi.org/10.1101/cshperspect.a020792.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Newton, David. "European Patent Office PatLib Conference, Seville, Spain, May 2007." World Patent Information 29, no. 4 (2007): 389–91. http://dx.doi.org/10.1016/j.wpi.2007.07.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Gall, Günter. "Legal documentation: The role of the European patent office." World Patent Information 7, no. 1-2 (1985): 151–58. http://dx.doi.org/10.1016/0172-2190(85)90046-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

roVice-President, P. G. M. Zwartkuis. "Welcoming address on behalf of the European patent office." Progress in Nuclear Energy 21 (January 1988): 1. http://dx.doi.org/10.1016/0149-1970(88)90010-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Herrero-Solana, Víctor, and Cristina Faba-Pérez. "European Patent Office (EPO) en Twitter: A content analysis." World Patent Information 74 (September 2023): 102213. http://dx.doi.org/10.1016/j.wpi.2023.102213.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Rogers, D. "European Patent Office, Enlarged Board of Appeal, rejects referral on software patents." Journal of Intellectual Property Law & Practice 5, no. 9 (2010): 618–19. http://dx.doi.org/10.1093/jiplp/jpq087.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Engel, Andreas. "Can a Patent Be Granted for an AI-Generated Invention?" GRUR International 69, no. 11 (2020): 1123–29. http://dx.doi.org/10.1093/grurint/ikaa117.

Full text
Abstract:
Abstract Three patent offices had to answer the question of whether a patent can be granted for an invention for which an Artificial Intelligence (AI) system called DABUS was named as inventor. All applications were dismissed, but for different reasons. While the European Patent Office focused on formal rules, the UK Intellectual Property Office considered more substantive aspects, and the US Patent and Trademark Office relied on statutory language. From a policy perspective, the decisions find support in the fact that there is no clear consensus for AI to be recognized as an inventor, and that difficult questions would ensue if this were accepted. From a doctrinal perspective, the decisions do not rule out the patentability of AI-assisted inventions in general, as it remains possible to designate a human inventor when AI has merely facilitated the inventive process. This leaves the question of who should own a patent for an AI-generated invention, if patentability for such inventions is considered desirable. A possible solution could be to grant ownership directly to the company operating or owning the AI.
APA, Harvard, Vancouver, ISO, and other styles
41

Heinrich, Sebastian, Florian Seliger, and Martin Wörter. "Appropriability and basicness of R&D: Identifying and characterising product and process inventions in patent data." PLOS ONE 17, no. 8 (2022): e0272225. http://dx.doi.org/10.1371/journal.pone.0272225.

Full text
Abstract:
We present a database that classifies all patent applications filed at either the United States Patent and Trademark Office (USPTO) or the European Patent Office (EPO) as being either product patents, process patents or ‘mixed patents’. We use the share of claims that refer to either product or process inventions which allows to classify all patent applications along a continuum of pure process patents and pure product patents. We find that process-oriented patents draw more on previous knowledge, are more original and more radical than product patents. Lower breadth of protection is positively associated with pure process patenting, whereas product and mixed variants can be protected more broadly. This characterisation uncovers heterogeneity of patented inventions that allows for a more sophisticated use of patent statistics. It can improve the accuracy of analyses, but also reveal new aspects related to property rights.
APA, Harvard, Vancouver, ISO, and other styles
42

Barycki, Michał. "Disclaimers in European Patent Applications." GRUR International 69, no. 12 (2020): 1204–16. http://dx.doi.org/10.1093/grurint/ikaa125.

Full text
Abstract:
Abstract A European patent application may be amended by, among others, deleting a part of the claimed subject matter under established conditions or by the incorporation of an undisclosed or disclosed disclaimer. Disclaimers are a useful tool in order to maintain the balance between the practical needs of applicants and the interests of third parties in legal clarity and completeness. The incorporation of disclaimers may not extend beyond the content of the European patent application as filed and the protection it confers. The purpose of this paper is to illustrate how an applicant can introduce a negative technical feature into the patent application in the light of the extensive judicial practice of the Technical and Enlarged Boards of Appeal of the European Patent Office. The author has analysed the criteria for disclaimers set out in decisions G 1/03, G 2/10 and G 1/16 in accordance with the general notion of patent law and requirements of patentability. Additionally, this problem was also characterized in the light of the judicial practice of national courts and legislations of the EU Member States.
APA, Harvard, Vancouver, ISO, and other styles
43

Doern, G. Bruce. "The European Patent Office and the political economy of European intellectual property policy." Journal of European Public Policy 4, no. 3 (1997): 388–403. http://dx.doi.org/10.1080/13501769780000061.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Piekut, Marlena. "Wydatki na działalność badawczo-rozwojową i aktywność patentowa w krajach europejskich." Wiadomości Statystyczne. The Polish Statistician 2013, no. 8 (2013): 60–74. http://dx.doi.org/10.59139/ws.2013.08.5.

Full text
Abstract:
This article aims to analyze spending on R&D activities and the number of patent applications to the European Patent Office. The study groupings similar to each other European countries in terms of spending on these activities and the number of patent applications. The cluster analysis with the Ward method was used to the country grouping.
APA, Harvard, Vancouver, ISO, and other styles
45

Köster, Christian. "A Micro-Comparison of Patent Law - Admissibility of Divisional Patent Applications Before the State Intellectual Property Office and the European Patent Office." Zeitschrift für Chinesisches Recht 18, no. 4 (2011): 255–65. https://doi.org/10.71163/zchinr.2011.255-265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Allen, Vicki, and Graham Matthew Lewis. "Are therapeutic antibodies still patentable at the European Patent Office?" Pharmaceutical Patent Analyst 6, no. 3 (2017): 91–94. http://dx.doi.org/10.4155/ppa-2017-0008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

DeBuyzer, Hendrik, Alain Leroy, and Simon Behmo. "Particularly active fields of technology at the European patent office." World Patent Information 8, no. 2 (1986): 117–21. http://dx.doi.org/10.1016/0172-2190(86)90010-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Beck, Michaël. "Conflicts of Laws in Proceedings Before the European Patent Office." IIC - International Review of Intellectual Property and Competition Law 48, no. 8 (2017): 925–52. http://dx.doi.org/10.1007/s40319-017-0643-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Hingley, Peter, and Serpil Bas. "Numbers and sizes of applicants at the European Patent Office." World Patent Information 31, no. 4 (2009): 285–98. http://dx.doi.org/10.1016/j.wpi.2009.04.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Goss, Ilaria. "Patenting polymorphs at the European Patent Office – an insider's view." Acta Crystallographica Section A Foundations and Advances 74, a2 (2018): e165-e165. http://dx.doi.org/10.1107/s2053273318092781.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'European Patent Office' for other source types:
Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography